News about MMA
Launch Media Release
MMA in the News
PRISM and St Vincents psilocybin trial for the terminally ill supported by Mind Medicine Australia and The Vasudhara Foundation
Johns Hopkins and NYU studies in psilocybin as a treatment for cancer-related psychological distress.
News outlets included CNN, New York Times, Newsweek, PBS Newshour, Science, Scientific American, The Atlantic, The Guardian, Time, and USA Today, among others.
Two clinical studies (released Dec. 1, 2016) examining the effect of psilocybin on symptoms of depression and anxiety in people with life-threatening cancer were released and covered by a number of media.
Vox June 27, 2016
Show Me the Evidence staff examines more than 50 studies analyzing the safety and efficacy of psychedelic drugs and psychedelic-assisted therapy and interviews researchers involved in the work. Vox, 2016
Zoe Cormier, Nature, May 17, 2016
Imperial College study provides preliminary support for the safety and efficacy of psilocybin as a therapy for treatment-resistant depression. Nature, 2016
Douglas Main, Newsweek, April 19, 2016
Researchers at the University of Zurich show that a small amount of psilocybin can reduce the distress caused by mild social exclusion and lessens activity in the area of the brain associated with this emotion. Newsweek, 2016
The Lancet Psychiatry, April 5, 2016
Drug-assisted psychotherapy as a possible alternative to existing pharmacological and psychological treatments. (Free registration required)
Washingtonian, January 7, 2014
Recent John’s Hopkins study on effecting addictive behaviour with psychedelics. Washingtonian, 2014